Your browser doesn't support javascript.
loading
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Saunders, Kevin O; Lee, Esther; Parks, Robert; Martinez, David R; Li, Dapeng; Chen, Haiyan; Edwards, Robert J; Gobeil, Sophie; Barr, Maggie; Mansouri, Katayoun; Alam, S Munir; Sutherland, Laura L; Cai, Fangping; Sanzone, Aja M; Berry, Madison; Manne, Kartik; Bock, Kevin W; Minai, Mahnaz; Nagata, Bianca M; Kapingidza, Anyway B; Azoitei, Mihai; Tse, Longping V; Scobey, Trevor D; Spreng, Rachel L; Rountree, R Wes; DeMarco, C Todd; Denny, Thomas N; Woods, Christopher W; Petzold, Elizabeth W; Tang, Juanjie; Oguin, Thomas H; Sempowski, Gregory D; Gagne, Matthew; Douek, Daniel C; Tomai, Mark A; Fox, Christopher B; Seder, Robert; Wiehe, Kevin; Weissman, Drew; Pardi, Norbert; Golding, Hana; Khurana, Surender; Acharya, Priyamvada; Andersen, Hanne; Lewis, Mark G; Moore, Ian N; Montefiori, David C; Baric, Ralph S; Haynes, Barton F.
Afiliación
  • Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Lee E; Department of Surgery, Duke University, Durham, NC, USA. kevin.saunders@duke.edu.
  • Parks R; Department of Immunology, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Martinez DR; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Li D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Chen H; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Gobeil S; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Barr M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Mansouri K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Alam SM; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Sutherland LL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Cai F; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Sanzone AM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Berry M; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Manne K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Bock KW; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Minai M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Nagata BM; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Kapingidza AB; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Azoitei M; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Tse LV; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Scobey TD; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Spreng RL; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Rountree RW; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • DeMarco CT; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Denny TN; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Woods CW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Petzold EW; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Tang J; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Oguin TH; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Sempowski GD; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Gagne M; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Douek DC; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Tomai MA; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Fox CB; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Seder R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Wiehe K; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Weissman D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Pardi N; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Golding H; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Khurana S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Acharya P; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Andersen H; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Lewis MG; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Moore IN; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
  • Baric RS; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.
Nature ; 594(7864): 553-559, 2021 06.
Article en En | MEDLINE | ID: mdl-33971664

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Resfriado Común / Reacciones Cruzadas / Anticuerpos Neutralizantes / Pandemias / Betacoronavirus / COVID-19 Límite: Animals / Female / Humans / Male Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Resfriado Común / Reacciones Cruzadas / Anticuerpos Neutralizantes / Pandemias / Betacoronavirus / COVID-19 Límite: Animals / Female / Humans / Male Idioma: En Revista: Nature Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos